Journal
Future Oncology
Publication Date
6-4-2024
Volume
20
Issue
30
First Page
2241
Last Page
2248
Document Type
Open Access Publication
DOI
10.1080/14796694.2024.2351351
Rights and Permissions
Azad N, Hu Z, Sahin I, Iyer R, Aranha O, Hochster H, Pathak P, Paulson AS, Kalyan A, Liao CY, Tran N, Kelley RK, Heestand G, Cosgrove D, El-Khoueiry A, Borad M, Gabrail NY, Majeed U, Du L, Kamath S, Shumway N, Shroff R, Goyal L, Rosales M, Javle M. COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC. Future Oncol. 2024;20(30):2241-2248. doi: 10.1080/14796694.2024.2351351. © 2024 Compass Therapeutics LLC. Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Recommended Citation
Azad, Nilofer; Aranha, Olivia; and et al., "COMPANION-002 a clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC." Future Oncology. 20, 30. 2241 - 2248. (2024).
https://digitalcommons.wustl.edu/oa_4/4544
